TNFRSF13C and infection: The implication is that BAFF-R might be a viable target for therapeutic intervention when infection-associated lymphoproliferation causes disease, aiming to reduce lymphoproliferation and the chance of oncogenic host mutations in GCs without the profound immunosuppression of memory B cell depletion.